Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal

BSE2395.0015.25 (+0.64 %)

PREV CLOSE ( ) 2379.75

OPEN PRICE ( ) 2399.65

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 501

TODAY'S LOW / HIGH ( )2390.00 2408.70

52 WK LOW / HIGH ( )1265.05 2531.95

NSE2394.9513.9 (+0.58 %)

PREV CLOSE( ) 2381.05

OPEN PRICE ( ) 2381.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 2394.95 (4)

VOLUME 8382

TODAY'S LOW / HIGH( ) 2381.00 2409.90

52 WK LOW / HIGH ( )1264.3 2540

Quarters

Select year

( in Million)

Particulars

Mar 2024

Dec 2023

Sep 2023

Jun 2023

Audited / UnAudited

UnAudited

Net Sales

10540.8

11051.5

10284.4

10210.4

Total Expenditure

7757.6

7910.8

7377.8

7497.2

PBIDT (Excl OI)

2783.2

3140.7

2906.6

2713.2

Other Income

355

135.9

213.3

317.5

Operating Profit

3138.2

3276.6

3119.9

3030.7

Interest

15.3

24.9

23.4

8.5

Exceptional Items

PBDT

3122.9

3251.7

3096.5

3022.2

Depreciation

342.5

342.6

337.1

331.8

Profit Before Tax

2780.4

2909.1

2759.4

2690.4

Tax

753.2

808.8

806.4

609.2

Provisions and contingencies

Profit After Tax

2027.2

2100.3

1953

2081.2

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

2027.2

2100.3

1953

2081.2

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

2027.2

2100.3

1953

2081.2

Equity Capital

252.7

Face Value (IN RS)

Reserves

Calculated EPS

16.04

16.62

15.45

16.47

Calculated EPS (Annualised)

64.17

66.49

61.82

65.88

No of Public Share Holdings

42542601

% of Public Share Holdings

33.79

PBIDTM% (Excl OI)

26.40

28.41

28.26

26.57

PBIDTM%

29.77

29.64

30.33

29.68

PBDTM%

29.62

29.42

30.10

29.59

PBTM%

26.37

26.32

26.83

26.34

PATM%

19.23

19.00

18.98

20.38

Notes

Risk Disclosures on Derivatives

Quarterly Results

AJANTA PHARMA LTD.